Introduction EP

Stroke continues to be a primary cause of long-term disability, with existing treatments providing limited recovery options and leaving many patients with substantial neurological impairments. Tackling this pressing unmet need is essential not only for enhancing the quality of life for millions affected by stroke annually, but also for inspiring entrepreneurial efforts to create transformative therapeutic solutions.



WHY?

Address the unmet need for effective stroke recovery, transforming lives by reducing long-term neurological damage.

HOW?

Delivering advanced cell therapy via intracerebral injection during the subacute stroke phase to maximize neural repair.

WHAT?

A novel cell therapy using genetically enhanced stem cells to restore neurological function in stroke patients.

map with the incidence of ischemic stroke every 100.000 inhabitants